Zepbound (tirzepatide): Complete Guide 2026
Zepbound (tirzepatide) is a once-weekly injectable dual GIP/GLP-1 receptor agonist approved specifically for chronic weight management in adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition. It is the same active ingredient as Mounjaro but branded for weight loss. In the SURMOUNT-1 trial, Zepbound produced unprecedented weight loss of approximately 20-26%, rivaling outcomes previously only achievable through bariatric surgery.
Enzo's Tip
Zepbound is like Enzo when he spots TWO laser dots at once — double the targets, double the results! This is the weight-loss superstar of the GLP-1 world. Start low and go slow, and let Enzo help you track every milestone on the way to your goals! 🐱✨
Track your Zepbound journey with Enzo
Dose tracking, side effect logging, and a cute cat cheering you on. Free to download.
Quick Facts
| Generic Name | tirzepatide |
| Manufacturer | Eli Lilly |
| Type | Injectable pen |
| Frequency | Once weekly |
| Primary Indication | Chronic weight management |
Zepbound Guides
Get Zepbound prescribed online — most patients approved in 24 hours
Licensed providers, no in-person visit, medication shipped to your door.
Enzo reminds you when your next Zepbound dose is due
Dose tracking, side effect logging, and a cute cat cheering you on. Free to download.
Frequently Asked Questions
The guide your doctor doesn't have time to give you
Your complete Zepbound playbook: week-by-week guide, what to eat when nothing sounds good, and how to manage every side effect. Free.
No spam. Unsubscribe anytime.
Medical Disclaimer: Enzo is a tracking companion, not a doctor. Always consult your healthcare provider before starting, stopping, or changing any medication. The information on this page is for educational purposes only and should not be considered medical advice. Individual results may vary.